Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Knorex Ltd. is a technology company specializing in digital marketing solutions and programmatic advertising. Its primary function is to develop platforms and tools that enable businesses to automate, optimize, and measure their online advertising campaigns across multiple channels. Knorex Ltd. leverages advanced data analytics, artificial intelligence, and cloud-based technologies to serve clients such as marketers, agencies, and other enterprises seeking greater efficiency and performance in their digital outreach. With a workforce of over one hundred employees as of late 2024, Knorex Ltd. focuses on innovations that impact sectors like e-commerce, travel, financial services, and consumer products—industries highly dependent on sophisticated online advertising strategies. The company’s role in the financial market stems from its position in the growing digital ad tech space, characterized by its drive to streamline ad buying and placement through automation. Knorex Ltd. has become notable for its scalable software platforms, which help shape market trends by improving targeting accuracy, reporting transparency, and campaign effectiveness for a diverse global clientele.
$0.52
+$0.19 (+57.58%)
EOD Aug 21, 2026
The business is unprofitable at the operating level (-50.91% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 24.0% YoY with margins expanding 40.3pp.
ROIC dropped from -119.28% to -123.53%, capital efficiency is deteriorating. Negative free cash flow of -$6M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$11M
▲ +24.0% YoY
Net Income (TTM)
-$6M
▲ +26.1% YoY
Op. Margin
-50.91%
▲ +40.3pp YoY
ROIC
-123.53%
▼ -4.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$6M
▲ +1.3% YoY
Op. Cash Flow (TTM)
-$5M
▲ +1.3% YoY
Net Debt
$5M
Cash & Equiv.
$825K
3Y CAGR: +37.3%
Continue Research
Knorex (KNRX)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Knorex scores 38/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Knorex scores 38 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -50.9% operating margin and a -123.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh KNRX's valuation and scores 38/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.